PharmGKB Blog
Monday, April 29, 2013

Updated UGT1A1 VIP Summary

›
We have updated the UGT1A1 VIP summary  to provide more in-depth information on this important pharmacogene. UGT1A1  is a member...
Wednesday, April 24, 2013

The PGRN Translational Pharmacogenetics Program (TPP) publishes paper on overcoming challenges of real-world implementation

›
The Translational Pharmacogenetics Program (TPP) is a Pharmacogenomics Research Network (PGRN)-led initiative with the goal to identif...
Tuesday, April 23, 2013

Implementing pharmacogenetics: more than one gene at a time

›
It has been well recognized that drug response is complex and determined by not only one gene, but rather by the interplay of multiple gene...
Wednesday, April 17, 2013

Clinical notes used for pharmacovigilance

›
A team at Stanford University have computationally extracted information from free-text clinical notes in medical records, in order to ident...
Monday, April 1, 2013

Venlafaxine Pathway

›
Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) marketed for the treatment of depression disorders. T he molecular targ...
Tuesday, March 26, 2013

Mycophenolic acid Pathway, Pharmacokinetics/Pharmacodynamics

›
We updated the  Mycophenolic acid Pathway  in collaboration with Kinjal Sanghavi and Dr. Vishal Lamba from the University of Minnesota. ...
Friday, March 22, 2013

GWAS in PGx: Pharmacogenomics Special Issue

›
This month's Future Medicine Pharmacogenomics Journal focuses on genome-wide association studies (GWAS) in PGx. Articles include highli...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.